Vie Ventures
Vie Ventures operates at the intersection of venture capital and disease philanthropy.
Our team leverages decades of experience, a proven track record in life sciences venture capital, a returns-oriented approach, and a network of strategic collaborators from across the biotech and disease philanthropy ecosystems to advance life-changing therapies and cures for patients.
A Panel Discussion About Our Strategy
Latest News
Jul 8, 2026
Boom Times For Autoimmune Disease Therapies
Jun 23, 2026
Food Allergy Science Initiative and Vie Ventures Announce Strategic Collaboration to Accelerate Progress Toward a Cure for Food Allergies
May 19, 2026
In Vivo – Vie Ventures Looks To Fill Autoimmune Disease Funding Gap
Feb 24, 2026
In Vivo – 20 Voices: What Does 2026 Hold For Biopharma?
Feb 19, 2026
Treg pioneer Bluestone joins Vie Ventures as it builds autoimmune portfolio
Feb 19, 2026